Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines

Despite the successes of current coronavirus disease 2019 (COVID-19) vaccines, waning immunity, the emergence of variants of concern, and breakthrough infections among vaccinees have begun to highlight opportunities to improve vaccine platforms. Real-world vaccine efficacy studies have highlighted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplonek, Paulina, Deng, Yixiang, Shih-Lu Lee, Jessica, Zar, Heather J., Zavadska, Dace, Johnson, Marina, Lauffenburger, Douglas A., Goldblatt, David, Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126214/
https://www.ncbi.nlm.nih.gov/pubmed/37182520
http://dx.doi.org/10.1016/j.xcrm.2023.101048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126214/
https://www.ncbi.nlm.nih.gov/pubmed/37182520
http://dx.doi.org/10.1016/j.xcrm.2023.101048

Ejemplares similares